Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 365

1.

The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study.

Nanwa N, Kwong JC, Krahn M, Daneman N, Lu H, Austin PC, Govindarajan A, Rosella LC, Cadarette SM, Sander B.

Infect Control Hosp Epidemiol. 2016 Jun 20:1-11. [Epub ahead of print]

PMID:
27322606
2.

Association of hospital and physician case volumes with cardiac monitoring and cardiotoxicity during adjuvant trastuzumab treatment for breast cancer: a retrospective cohort study.

Chin-Yee NJ, Yan AT, Kumachev A, Ko D, Earle C, Tomlinson G, Trudeau ME, Krahn M, Krzyzanowska M, Pal R, Brezden-Masley C, Gavura S, Lien K, Chan K.

CMAJ Open. 2016 Feb 18;4(1):E66-72. doi: 10.9778/cmajo.20150033. eCollection 2016 Jan-Mar.

3.

Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study.

Gong IY, Verma S, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, Krahn MD, Krzyzanowska MK, Brezden-Masley CB, Gavura S, Peacock S, Chan KK.

Breast Cancer Res Treat. 2016 Jun;157(3):535-44. doi: 10.1007/s10549-016-3823-y. Epub 2016 Jun 6.

PMID:
27271767
4.

Direct-Acting Antiviral Agents for Chronic Hepatitis C Genotype 1 [Internet].

Murphy G, Farah B, Wong W, Krahn M, Wells G, Chen L, Kelly S, Kaunelis D, Blouin J, Lee K, Carrie A.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Oct.

5.

Disparities in a provision of in-hospital post-arrest interventions for out-of-hospital cardiac arrest (OHCA) in the elderly population-protocol for a systematic review.

Bielecki JM, Wong J, Mitsakakis N, Shah PS, Krahn MD, Rac VE.

Syst Rev. 2016 Apr 7;5(1):55. doi: 10.1186/s13643-016-0234-4.

6.

Drugs for Chronic Hepatitis C Infection: Cost-Effectiveness Analysis [Internet].

Wong W, Krahn M, Lee K, Singh S.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Jan.

7.

Calf hypertrophy and gastrocnemius MRI short tau inversion recovery (STIR) hyperintensity in a patient with asymptomatic hyperCKemia caused by caveolin-3 gene mutation.

Renard D, Erny F, Figarella-Branger D, Krahn M.

Neuromuscul Disord. 2016 Apr-May;26(4-5):326-7. doi: 10.1016/j.nmd.2016.02.009. Epub 2016 Feb 23. No abstract available.

PMID:
27061274
8.

Comparing targeted exome and whole exome approaches for genetic diagnosis of neuromuscular disorders.

Gorokhova S, Cerino M, Mathieu Y, Courrier S, Desvignes JP, Salgado D, Béroud C, Krahn M, Bartoli M.

Appl Transl Genom. 2015 Sep 4;7:26-31. doi: 10.1016/j.atg.2015.07.006. eCollection 2015 Dec.

9.

Coverage Analysis of Lists of Genes involved in Heterogeneous Genetic Diseases following Benchtop Exome Sequencing using the Ion Proton.

Lacoste C, Desvignes JP, Salgado D, Pecheux C, Villard L, Bartoli M, Beroud C, Levy N, Badens C, Krahn M.

J Genet. 2016 Mar;95(1):203-8. No abstract available.

PMID:
27019452
10.
11.

Population-based trends in systemic therapy use and cost for cancer patients in the last year of life.

Pataky RE, Cheung WY, de Oliveira C, Bremner KE, Chan KK, Hoch JS, Krahn MD, Peacock SJ.

Curr Oncol. 2016 Feb;23(Suppl 1):S32-41. doi: 10.3747/co.23.2946. Epub 2016 Feb 29.

12.

Management of neck pain and associated disorders: A clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.

Côté P, Wong JJ, Sutton D, Shearer HM, Mior S, Randhawa K, Ameis A, Carroll LJ, Nordin M, Yu H, Lindsay GM, Southerst D, Varatharajan S, Jacobs C, Stupar M, Taylor-Vaisey A, van der Velde G, Gross DP, Brison RJ, Paulden M, Ammendolia C, David Cassidy J, Loisel P, Marshall S, Bohay RN, Stapleton J, Lacerte M, Krahn M, Salhany R.

Eur Spine J. 2016 Jul;25(7):2000-22. doi: 10.1007/s00586-016-4467-7. Epub 2016 Mar 16. Review.

PMID:
26984876
13.

Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.

Crowther GJ, Hillesland HK, Keyloun KR, Reid MC, Lafuente-Monasterio MJ, Ghidelli-Disse S, Leonard SE, He P, Jones JC, Krahn MM, Mo JS, Dasari KS, Fox AM, Boesche M, El Bakkouri M, Rivas KL, Leroy D, Hui R, Drewes G, Maly DJ, Van Voorhis WC, Ojo KK.

PLoS One. 2016 Mar 2;11(3):e0149996. doi: 10.1371/journal.pone.0149996. eCollection 2016.

14.

Using Phase-Based Costing of Real-World Data to Inform Decision-Analytic Models for Atrial Fibrillation.

Tawfik A, Wodchis WP, Pechlivanoglou P, Hoch J, Husereau D, Krahn M.

Appl Health Econ Health Policy. 2016 Jun;14(3):313-22. doi: 10.1007/s40258-016-0229-2.

PMID:
26924098
15.

The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?

Sander B, Wong WW, Yeung MW, Ormanidhi O, Atkin K, Murphy J, Krahn M, Deeks SL.

Vaccine. 2016 Apr 7;34(16):1936-44. doi: 10.1016/j.vaccine.2016.02.016. Epub 2016 Feb 15.

PMID:
26892739
16.

Patients' Values Related to Treatment Options for Teeth with Apical Periodontitis.

Azarpazhooh A, Dao T, Ungar WJ, Da Costa J, Figueiredo R, Krahn M, Friedman S.

J Endod. 2016 Mar;42(3):365-70. doi: 10.1016/j.joen.2015.11.022. Epub 2016 Jan 6.

PMID:
26778269
17.

Authors' response.

Abrahamyan L, Pechlivanoglou P, Krahn M, Carrasco-Labra A, Brignardello-Petersen R, Glick M, Guyatt GH, Azarpazhooh A.

J Am Dent Assoc. 2016 Jan;147(1):6-7. doi: 10.1016/j.adaj.2015.11.006. No abstract available.

PMID:
26743796
18.

Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria.

Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sroczynski G, Paulden M, Kluibenschädl M, Krahn M, Siebert U.

Springerplus. 2015 Dec 1;4:752. doi: 10.1186/s40064-015-1440-6. eCollection 2015.

19.

Dysferlinopathy in Iran: Clinical and genetic report.

Fatehi F, Nafissi S, Urtizberea JA, Blanck-Labelle V, Lévy N, Krahn M, Dbouk MB, Attarian S.

J Neurol Sci. 2015 Dec 15;359(1-2):256-9. doi: 10.1016/j.jns.2015.11.009. Epub 2015 Nov 11.

PMID:
26671124
20.

A multi-level qualitative analysis of Telehomecare in Ontario: challenges and opportunities.

Hunting G, Shahid N, Sahakyan Y, Fan I, Moneypenny CR, Stanimirovic A, North T, Petrosyan Y, Krahn MD, Rac VE.

BMC Health Serv Res. 2015 Dec 9;15:544. doi: 10.1186/s12913-015-1196-2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk